Articles for the ‘’ Category

Clyde & Co – UK Life Sciences Sector in Election Year (Jan 2024; rev Feb 24) The next UK general election has to take place before 28 January 2025, current indications are that it could take place in October or November 2024. After 13 years in power, opinion polls suggest that Mr Sunak’s Conservative Party will lose power and be replaced by Sir Keir Starmer KC’s Labour as the governing party.

In this article, Ralph Cox and Nii-Lante Bannerman of Clyde & Co LLP, consider the Conservative Government’s approach to the UK’s life sciences sector over recent years and how that might change under Labour.

An amendment to the Act on Medicinal Products entered into effect as of 1 January 2024, imposing numerous new obligations on marketing authorisation holders, distributors and pharmacies, and expanding the existing powers of administrative authorities. The changes are primarily aimed at ensuring the availability of medicinal products for the needs of patients in the Czech Republic and increasing the resilience of the market to supply shortages of medicinal products.

This blog post mainly focuses on the CJEU’s findings regarding the responsibility of parallel importers for ensuring the display of the original batch number on the product packaging.

Food law is extensively harmonized throughout the EU, but national law still has a role to play. In this short article, we look at three developments in Belgian food law that have taken place in 2023: the amendments to the Food Safety Agency’s administrative fining regime, the introduction of nutrivigilance, and the announced revision of the food hygiene legislation.